Am J Transplant, Volume 16, Suppl 3 Archives - Page 44 of 180 - ATC Abstracts

2016 American Transplant Congress
Is MELD Score a Significant Predictor of Post-Transplant Mortality? An Old Issue with Simple Answer.
A. Rahnemai-Azar,¹ J. Perkins,¹ M. Montenovo,¹ S. Rayhill,¹ R. Bakthavatsalam,¹ N. Leca,² C. Blosser,² I. Di Castro,² R. Bhattacharya,³ J. Reyes,¹ L. Sibulesky.¹
¹Surgery, University of Washington, Seattle, WA; ²Nephrology, University of Washington, Seattle, WA; ³Hepatology, University of Washington, Seattle, WA.
The predictive value of the Model for End-Stage Liver Disease (MELD) score for post-transplant survival has been under constant debate. Some investigators tried to introduce…
2016 American Transplant Congress
Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
T. Zens, G. Leverson, R. Redfield, P. Chlebeck, L. Zitur, D. Kaufman, L. Fernandez.
Surgery, University of Wisconsin, Madison, WI.
Introduction: Renal transplant outcomes are a result of a combination of donor and recipient factors. In 2014, the nomenclature used to describe donor quality was…
2016 American Transplant Congress
Eversion Endarterectomy of the Deceased Donor Renal Artery to Prevent Kidney Discard.
M. Khan, K. Jones, H. El-Hennawy, A. Farney, J. Rogers, G. Orlando, R. Stratta.
Surgery, Wake Forest, Winston-Salem, NC.
Deceased donor (DD) kidneys exhibiting severe atherosclerosis with hard ulcerative occlusive plaque extending into the renal artery (RA) may represent a contraindication to utilization. Limited…
2016 American Transplant Congress
Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid Organ Transplant Recipients.
D. Newland, A. Edwards, R. Hall, P. Maxwell.
University Transplant Center, University Health System and The University of Texas Health Science Center at San Antonio, San Antonio, TX.
Background: Post-transplant diabetes mellitus (PTDM) can lead to significant morbidity and cardiovascular death with a functioning graft. A paucity of literature exists regarding glycemic control…
2016 American Transplant Congress
The Impact of Gender Discordance on Graft Survival Among Liver Transplant Recipients.
J. Moore, X. Luo, A. Massie, T. Purnell, D. Mogul, D. Segev.
Johns Hopkins School of Medicine, Baltimore.
Past studies have shown inferior liver graft survival in gender-discordant recipient/donor pairings compared to gender-matched pairings, particularly in male recipients of female donor livers. However,…
2016 American Transplant Congress
A Call for a New Paradigm of Organ Allocation within the Confines of MELD for Those Who Are Not “the Sickest”.
T. Baker, A. Siarris, P. Accoh, D. Ladner.
Comprehensive Transplant Center, Northwestern University, Chicago, IL.
BACKGROUND: Liver Allocation policy in the United States is in dynamic flux, with revisions in policy reflecting designs to optimize access to and outcomes for…
2016 American Transplant Congress
Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.
S. Pouch,¹ E. Lease,² T. Bogdanovich,³ D. Ho,⁴ R. Miller,⁵ M. Estabrook,⁶ T. Babu,⁷ C. Kotton,⁷ C. Shaver,⁸ L. Thomas,⁸ S. Aslam,⁹ T. McCarty,¹⁰ J. Garcia-Diaz,¹¹ K. Doucette,¹² S. Kirkby,¹³ D. van Duin.¹⁴
¹Ohio State University, Columbus, OH; ²University of Washington, Seattle, WA; ³University of Pittsburgh, Pittsburgh, PA; ⁴Stanford University, Stanford, CA; ⁵University of Iowa, Iowa City, IA; ⁶Washington University St. Louis, St. Louis, MO; ⁷Massachusetts General Hospital, Boston, MA; ⁸Vanderbilt University, Nashville, TN; ⁹University of California San Diego, San Diego, CA; ¹⁰University of Alabama, Birmingham, AB; ¹¹Ochsner Clinic Foundation, New Orleans, LA; ¹²University of Alberta, Edmonton, AB, Canada; ¹³Nationwide Children's Hospital, Columbus, OH; ¹⁴University of North Carolina, Chapel Hill, NC.
Background: The impact of pre-lung transplant (LT) pan-drug-resistant Pseudomonas aeruginosa (PDR PsA) colonization on post-LT mortality and bronchiolitis obliterans syndrome (BOS) rates in cystic fibrosis…
2016 American Transplant Congress
The First 48 Months of an Australian Renal and Liver Organ Transplant Dermatology Database.
L. Ge,^1,2 P. Lowe.^1,2
¹Department of Dermatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; ²Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
PurposeThere have been few studies of non-melanoma skin cancers in the Australian cohort, a population unique for its high ambient UV radiation and sun-long lifestyle.…
2016 American Transplant Congress
Kidney Graft Homing of De Novo Donor Specific HLA Antibodies Is an Early Step within the Antibody-Mediated Graft Damage Process.
A. Nocera,¹ M. Cioni,² A. Tagliamacco,¹ A. Innocente,³ I. Fontana,⁴ A. Magnasco,² A. Nocco,³ A. Sementa,² G. Garibotto,¹ G. Ghiggeri,² M. Cardillo,³ P. Comoli,⁵ F. Ginevri.²
¹Transplant Immunology and Nephrology, University of Genova, Genova, Italy; ²Nephrology and Pathology, G. Gaslini Institute, Genova, Italy; ³Transplantation Immunology, Fondazione Cà Granda Ospedale Maggiore Policlinico, Milano, Italy; ⁴Kidney Transplant Surgery, IRCCS S.Martino-IST, Genova, Italy; ⁵Pediatric Hematology/Oncology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy.
In this study, by a parallel analysis on sera and graft biopsies we have analyzed, in a pediatric cohort of unsensitized recipients of a first…
2016 American Transplant Congress
Treatment of Late Antibody-Mediated Rejection: Observations from Clinical Practice.
G. Einecke,¹ J. Bräsen,² A. Schwarz,¹ H. Haller,¹ F. Njau.¹
¹Nephrology, Medical School of Hannover, Hannover, Germany; ²Pathology, Medical School of Hannover, Hannover, Germany.
Antibody-mediated rejection (AMR) is a major cause of late renal allograft failure. The benefit of treatment of chronic ABMR is unknown. Currently there is no…